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Abstract
Rationale: Infectious keratitis is a relatively uncommon but potentially sight-threatening complication of laser in situ keratomileusis
(LASIK). Mycobacterial keratitis is usually regarded as late onset keratitis among post-LASIK keratitis. There has been no
documented case of Mycobacterium intracellulare post-LASIK keratitis of a long-latent period.
Patient concerns: A 36-year-old man was referred to our out-patient clinic, for persistent corneal epithelial defect with
intrastromal inﬁltration. He had undergone uneventful bilateral LASIK procedure 4 years before. He complained decreased vision,
accompanied by ocular pain, photophobia, and redness in his left eye for 7 months.
Diagnosis: Lamellar keratectomy was taken using femtosecond laser. Bacterial culture with sequenced bacterial 16s ribosomal
DNA conﬁrmed the organism to be M intracellulare.
Interventions: After 3 months of administration of topical clarithromycin, amikacin, and moxiﬂoxacin, the corneal epithelial defect
was resolved and the inﬁltration was much improved. However, newly developed diffuse haziness with surrounding granular
inﬁltration in the central cornea was noted. Drug toxicity was suspected and topical moxiﬂoxacin was discontinued, resulting in
resolution of the diffuse haze with inﬁltration.
Outcome: The patient was followed up regularly without medication thereafter and recurrence was not found for 7 years.
Lessons: This case presents the ﬁrst case ofM intracellulare keratitis after LASIK. LASIK surgeons should aware that post-LASIK
keratitis can develop long after the operation and careful suspicion of infectious disease with meticulous diagnostic test is needed.
Abbreviations: BCVA = best corrected visual acuity, LASIK = laser in situ keratomileusis, NTM = nontuberculous mycobacteria.
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Infectious keratitis is a relatively uncommon but potentially sight-
threatening complication of laser in situ keratomileusis (LASIK).
Gram-positivemicroorganisms and nontuberculous mycobacteriaEditor: N/A.
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1(NTM) are the most commonly isolated organisms. The most
frequently NTM species causing post-LASIK keratitis are
Mycobacterium chelonae and Mycobacterium fortuitum, and
only 4 other species, Mycobacterium abscessus, Mycobacterium
mucogenicum, Mycobacterium terrae, and Mycobacterium szul-
gai, have been identiﬁed to cause post-LASIK keratitis.[1–5]
Mycobacterial keratitis is usually regarded as late onset keratitis
among post-LASIK keratitis, when compared with those by gram-
positive bacteria, and the most deferred onset post-LASIK NTM
keratitis was 3.5 months after LASIK.[1,6]
There are a few reports about late onset bacterial keratitis more
than 2 years after LASIK.[7–9] There was, however, no report of
keratitis byNTMwith such long-latent period after LASIK. Here,
we present a case of infectious keratitis, which occurred 4 years
after LASIK, caused by M intracellulare. It was diagnosed
through lamellar keratectomy followed by culture and managed
successfully by long-term administration of topical clarithromy-
cin and amikacin. To the best of our knowledge, this is the ﬁrst
documented case of M intracellulare post-LASIK keratitis of a
long-latent period. Ethical approval was not necessary due to the
nature of this study (single case report), and the informed consent
was obtained from the patient.2. Case presentation
A 36-year-old man was referred to our out-patient clinic, for
persistent corneal epithelial defect with intrastromal inﬁltration.
He had undergone uneventful bilateral LASIK procedure 4 years
Figure 1. (A) Slit-lamp examination at presentation shows 2 round corneal inﬁltrates with surrounding edema at 3 O’clock position at initial presentation. (B) Corneal
optical coherence tomography shows the LASIK ﬂap was perforated (marked as white arrow) and the inﬁltration (marked as arrow head) originated from LASIK ﬂap
interface. (C) Newly developed LASIK ﬂap perforation on the previously increased corneal inﬁltrate was noted in slit lamp examination after use of topical
moxiﬂoxacin for 1 month (marked as arrow heads). (D) Corneal optical coherence tomography shows perforated ﬂap where the inﬁltration increased previously. (E)
Six months of topical clarithromycin, amikacin, and moxiﬂoxacin to post-LASIK Mycobacterium intracellulare infection produced diffuse epithelial haziness with
surrounding small dot-shaped inﬁltration (marked as arrow heads). (F) Corneal optical coherence tomography conﬁrms this opacity is conﬁned to epithelial layer
(marked as white arrow). The inﬁltration was resolved soon after discontinuation of moxiﬂoxacin.
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pain, photophobia, and redness in his left eye for 7 months. His
medical record showed that he was diagnosed of anterior uveitis
and was prescribed topical steroid for 1 month before the
initiation of present symptom and sign of keratitis. His corneal
epithelial defect and inﬁltration was not noticed at the beginning
of topical steroids application. Previous episodes of epithelial
defect, corneal edema, and inﬁltration at LASIK ﬂap interface
were improved with use of topical antibiotics and steroids,
but not resolved completely during 7 months before he visited
our clinic.
At presentation to our clinic, his right eye was normal with best
corrected visual acuity (BCVA) 20/20, while left eye showed 1
paracentral perforated LASIK ﬂap and 1 anterior stromal opacity
along the LASIK ﬂap interface outside of the pupil at 3 O’clock
position (Fig. 1A and B) with BCVA 20/40. Topical 0.5%
moxiﬂoxacin eyedrops (Vigamox, Alcon, TX) was prescribed
every 2h. However, ﬂap perforation occurred and density of the
remained corneal inﬁltrate outside of the perforated area
increased during next 2 months (Fig. 1C and D). Lamellar
keratectomy was taken for bacterial and fungal culture with
corneal tissue, using femtosecond laser (IntraLase, IntraLase2Corp., Irvine, CA) with size of 2.0mm in diameter and 290mm in
depth at the site of inﬁltrative lesion (Fig. 2A). Tissue specimen
was sent for the microbiological study including microbiological
cultures and bacterial DNA sequencing. Bacterial culture with
corneal tissue yielded growth of nontuberculosis mycobacterium.
Sequenced bacterial 16s ribosomal DNA conﬁrmed the organism
to be M intracellulare. Topical clarithromycin 1% and topical
amikacin 4% every 2 hwere prescribedwith topical moxiﬂoxacin
4 times daily in the left eye. Corneal epithelial debridement was
performed to allow more rapid penetration of the topical
antibiotics into the cornea. After 3 months of administration of
topical clarithromycin, amikacin, and moxiﬂoxacin, the corneal
epithelial defect was resolved and the inﬁltration was much
improved (Fig. 2B).
However, newly developed diffuse haziness (2.5mm 1.5mm
sized) with surrounding granular inﬁltration in the central cornea
was noted 6 months after initiation of topical clarithromycin,
amikacin, and moxiﬂoxacin (Fig. 1E and F). Drug toxicity was
suspected and topical moxiﬂoxacin was discontinued while
clarithromycin and amikacin were tapered to 4 times daily
resulting in resolution of the diffuse haze with inﬁltration.
Topical amikacin was maintained for 10 months after diagnosis,
[1]
Figure 2. (A) Slit lamp ﬁnding 1 day after lamellar keratectomy with femtosecond laser. Newly developed epithelial defect and inﬁltrative lesion was thought to be the
site of active infection, so it was removed completely. (B) After administrating topical clarithromycin, amikacin, and moxiﬂoxacin for 3 months to post-LASIK
Mycobacterium intracellulare infection, slit lamp examination showed completely resolved epithelial defect and inﬁltrative lesion. (C) Stabilized lesion with stromal
opacity was noted 7 years after initial presentation.
Ko et al. Medicine (2017) 96:51 www.md-journal.comand topical clarithromycin was prescribed for 13 months. The
patient was followed up regularly without medication thereafter
and recurrence was not found for 7 years. His corrected visual
acuity was 20/20 (Fig. 2C).3. Discussion
In the literature review, there are 6 species of mycobacterium
which had been reported as possible cause of post-LASIK3keratitis. Mycobacterium intracellulare is one of the most
commonly encountered NTM in the United States which most
often affects the lungs. It is classiﬁed to Runyon classiﬁcation III,
which is nonchromatogenic, slow growing organism.[10]Myco-
bacterium intracellulare keratitis has been reported rarely[11–13]
but M intracellulare keratitis after LASIK was not described yet.
NTM induced post-LASIK keratitis may be caused by
suboptimal sterile preparation of patients and multiple uses of
microkeratome blades.[1,5,14] In the usual post-LASIK mycobac-
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potential space beneath LASIK ﬂap during surgical procedure
and maybe in dormant state until its presentation.
Some cases of post-LASIK keratitis by bacteria other than
NTM show latent period of keratitis after the surgery longer
than 2 years.[7–9] These reports explain the bacteria, mostly
pseudomonas and staphylococcus, invaded through small
epithelial break at the ﬂap margin to the interface of lamellar
ﬂap. In our case, infection from ﬂap margin is unlikely because
mycobacteria are nonﬂagellated and nonmotile bacteria and the
major inﬁltration in our case was present at the paracentral
area of cornea, relatively sparing the margin of ﬂap.[15]
Therefore, the bacteria inoculated during LASIK might be in
the dormant state during 4 years after procedure to be activated
later or might penetrate to the LASIK ﬂap interface through the
small epithelial break recently before the initiation of the
keratitis.
The NTM keratitis is difﬁcult to treat due to resistance to
conventional antibiotics, slow response to therapy requiring
protracted treatment period with combined drugs of amikacin,
clarithromycin, and 4th-generation ﬂuoroquinolones.[2,4,6,16–18]
Multidrug combination therapy has been effective in prior case.
The length of medical treatment of NTM keratitis is typically
prolonged and no speciﬁc guidelines regarding the duration of
treatment have been determined. In post-LASIK NTM keratitis
cases, treatment duration has ranged from 4 weeks to 9 months,
with most resolving after 6 to 8 weeks of treatment.[17,19] In our
cases, keratitis was mostly resolved after 3 months of treatment,
and treatment was maintained for 13 months and recurrence was
not occurred during 7 years of follow up.
Management of NTM keratitis in post-LASIK patient with
topical clarithromycin and amikacin is sometimes interrupted
due to toxicity of the drugs.[11,13] Surface toxicity and patient
discomfort for long period of treatment may limit the dosage of
the medication. In our case, the haziness was conﬁned to the
epithelium of cornea. Topically administrated ciproﬂoxacin is
well known to cause white corneal deposition of drug, and
several other quinolones are reported to cause corneal precip-
itates.[20] Although corneal precipitates have not been reported
with long-term use of moxiﬂoxacin, it might have resulted in the
epithelial opacity in our case where it was used for 8 months 4
times a day.
In conclusion, we present the ﬁrst case of M intracellulare
keratitis after LASIK. LASIK surgeons should aware that post-
LASIK keratitis can develop long after the operation and careful
suspicion of infectious disease with meticulous diagnostic test is
needed. After diagnosis of NTM keratitis, combination of topical4antibiotics including clarithromycin, amikacin and 4th-genera-
tion quinolone can be considered.References
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